[1] |
Gutmann DH, Aylsworth A, Carey JC, et al. The diagnostic evaluation and multidisciplinary management of neuro⁃fibromatosis 1 and neurofibromatosis 2[J]. JAMA, 1997,278(1):51⁃57.
|
[2] |
Zhang J, Tong H, Fu X, et al. Molecular Characterization of NF1 and Neurofibromatosis Type 1 Genotype⁃Phenotype Correlations in a Chinese Population[J]. Sci Rep, 2015,5:11291. doi: 10. 1038/srep11291.
|
[3] |
Mautner VF, Kluwe L, Friedrich RE, et al. Clinical characterisation of 29 neurofibromatosis type⁃1 patients with molecularly ascertained 1.4 Mb type⁃1 NF1 deletions[J]. J Med Genet, 2010,47(9):623⁃630. doi: 10.1136/jmg.2009.075937.
|
[4] |
孙忠辉, 李明, 郭韫懿, 等. 基因检测诊断仅有咖啡色斑表现的儿童Ⅰ型神经纤维瘤病一例[J]. 中华皮肤科杂志, 2013,46(7):511⁃512. doi: 10.3760/cma.j.issn.0412⁃4030.2013.07.019.
|
[5] |
Nemethova M, Bolcekova A, Ilencikova D, et al. Thirty⁃nine novel neurofibromatosis 1 (NF1) gene mutations identified in Slovak patients[J]. Ann Hum Genet, 2013,77(5):364⁃379. doi: 10.1111/ahg.12026.
|
[6] |
倪成. 遗传性角化性皮肤病基因型-表型关系研究[D]. 上海: 上海交通大学, 2016.
|
[7] |
Mao B, Chen S, Chen X, et al. Clinical characteristics and spectrum of NF1 mutations in 12 unrelated Chinese families with neurofibromatosis type 1[J]. BMC Med Genet, 2018,19(1):101. doi: 10.1186/s12881⁃018⁃0615⁃8.
|
[8] |
Corsello G, Antona V, Serra G, et al. Clinical and molecular characterization of 112 single⁃center patients with Neurofibromatosis type 1[J]. Ital J Pediatr, 2018,44(1):45. doi: 10.1186/s13052⁃018⁃0483⁃z.
|
[9] |
Wimmer K, Yao S, Claes K, et al. Spectrum of single⁃ and multiexon NF1 copy number changes in a cohort of 1,100 unselected NF1 patients[J]. Genes Chromosomes Cancer, 2006,45(3):265⁃276. doi: 10.1002/gcc.20289.
|
[10] |
Zhu L, Zhang Y, Tong H, et al. Clinical and molecular characterization of NF1 patients: single⁃center experience of 32 patients from China[J]. Medicine (Baltimore), 2016,95(10):e3043. doi: 10.1097/MD.0000000000003043.
|
[11] |
Orzan F, Stroppi M, Venturin M, et al. Breakpoint characterization of a novel NF1 multiexonic deletion: a case showing expression of the mutated allele[J]. Neurogenetics, 2008,9(2):95⁃100. doi: 10.1007/s10048⁃007⁃0115⁃z.
|
[12] |
Jang MA, Kim YE, Kim SK, et al. Identification and characterization of NF1 splicing mutations in Korean patients with neurofibromatosis type 1[J]. J Hum Genet, 2016,61(8):705⁃709. doi: 10.1038/jhg.2016.33.
|
[13] |
Ars E, Serra E, García J, et al. Mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1[J]. Hum Mol Genet, 2000,9(2):237⁃247. doi: 10.1093/hmg/9.2.237.
|
[14] |
Faravelli F, Upadhyaya M, Osborn M, et al. Unusual clustering of brain tumours in a family with NF1 and variable expression of cutaneous features[J]. J Med Genet, 1999,36(12):893⁃896.
|
[15] |
Trevisson E, Morbidoni V, Forzan M, et al. The Arg1038Gly missense variant in the NF1 gene causes a mild phenotype without neurofibromas[J]. Mol Genet Genomic Med, 2019,7(5):e616. doi: 10.1002/mgg3.616.
|
[16] |
Koczkowska M, Callens T, Gomes A, et al. Expanding the clinical phenotype of individuals with a 3⁃bp in⁃frame deletion of the NF1 gene (c.2970_2972del): an update of genotype⁃phenotype correlation[J]. Genet Med, 2019,21(4):867⁃876. doi: 10.1038/s41436⁃018⁃0269⁃0.
|
[17] |
Rojnueangnit K, Xie J, Gomes A, et al. High incidence of noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p.arg1809: genotype⁃phenotype correlation[J]. Hum Mutat, 2015,36(11):1052⁃1063. doi: 10.1002/humu.22832.
|
[18] |
Guo Y, Zhu Y, Zhang D, et al. Typical Chinese pedigree of autosomal dominant genetic disease: neurofibromatosis type 1 with a novel frame⁃shift mutation[J]. J Dermatol, 2017,44(8):e188⁃e189. doi: 10.1111/1346⁃8138.13899.
|
[19] |
Griffiths S, Thompson P, Frayling I, et al. Molecular diagnosis of neurofibromatosis type 1: 2 years experience[J]. Fam Cancer, 2007, 6(1):21⁃34. doi: 10.1007/s10689⁃006⁃9001⁃3.
|